Our findings reveal that SNHG26 functions as an oncogenic lncRNA that promotes CRC progression through post‐transcriptional destabilisation of CDKN2A mRNA, resulting in enhanced cell proliferation, resistance to cuproptosis and immune evasion. Here, SNHG26 is linked to colorectal carcinoma.